Author
Listed:
- Farhana Afroze
(Jagannath University, Bangladesh)
- Md. Zahid Hassan
(Jagannath University, Bangladesh)
- Md. Zahid Hasan Rana
(Jagannath University, Bangladesh)
- Shilpi Akter
(Jagannath University, Bangladesh)
- Md. Imran Hossen
(Jagannath University, Bangladesh)
- Syeda Tasneem Towhid
(Jagannath University, Bangladesh)
Abstract
The opportunistic pathogen Pseudomonas aeruginosa has been recognized as a major cause of nosocomial infection due to resistance to multiple classes of antibiotics. This study reports presence of carbapenem resistance genes in clinical Pseudomonas isolates from Dhaka, Bangladesh, as well as their resistance to some common disinfectants (benzylkonium chloride and chlorhexidine gluconate). Twenty three samples were collected from two hospitals and one diagnostic center from different locations in Dhaka city. Among these, 16 isolates were identified as Pseudomonas sp. from growth on Cetrimide Agar, standard biochemical tests (catalase, oxidase and triple sugar iron, urea, Sulphur Indole Motility medium, Lysine Iron Agar, Methyl Red-Voges Proskaeur medium, nitrate, citrate) and IasL/R-gene targeted PCR. Molecular characterization revealed three of the isolates contained 2.3kb to 2.5 kb plasmids. The genome of 6 isolates contained blaGIM gene encoding metallo-beta-lactamase variant (German), but none of isolates were resistant against imipenem group of antibiotics (meropenem, gentamicin, cefixime, imipenem). Therefore the isolates are genetically potent to resist antibiotics belonging to imipenem group, but are still sensitive to the antibiotics in culture. 3% Benzylkonium chloride and 0.5% chlorhexidine gluconate has slightly synergistic effect in inhibiting Pseudomonas sp. in representative isolates as their Fractional Inhibitory Concentration Index value ranges between 0.22 and 0.5. Taken together, Pseudomonas sp. isolates harboring potential virulent genes and imipenem-resistance genes could be inhibited more effectively in vitro if more than one suitable disinfectants are applied combinedly.
Suggested Citation
Handle:
RePEc:epw:ejbio0:v:3:y:2022:i:4:id:17389
DOI: 10.24018/ejbio.2022.3.4.389
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:epw:ejbio0:v:3:y:2022:i:4:id:17389. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Support Team (email available below). General contact details of provider: https://eu-opensci.org/index.php/ejbio .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.